PROM1 and cancer: Compared with WT HCT116 cell, CD133-knockdown cell possessed weaker PI3K–AKT pathway activity, which indicated the potential to inhibit the PI3K–AKT pathway to prevent cancer cell growth (Fig. EV1B).